Abstract
Over the past decades, tremendous advances have been made in the understanding, diagnosis, and treatment of cardiovascular disease. However, we now face new challenges, including an aging population and increases in metabolic risk factors, that threaten to slow and even reverse these gains. To overcome these new challenges, fundamental insights from the life sciences must be integrated with advances from the physical sciences to develop novel molecular tools to better diagnose, monitor, and treat this complex disease. Nanotechnology has emerged from the intersection of several disciplines and, if combined with our evolving molecular understanding of atherogenesis, has the potential to revolutionize our management of patients at risk for or with existing cardiovascular disease. However, to realize this potential, we must understand the principles governing the interactions between nanomaterials and biological systems. This review explores nanoparticle attributes and how they can be leveraged to develop novel molecular tools for the diagnosis and treatment of cardiovascular disease.
Similar content being viewed by others
References
Libby P, Ridker PM, Hansson GK. Nature. 2011;473:317.
Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Nat Rev Drug Discov. 2011;10:835.
Godin B, Sakamoto JH, Serda RE, Grattoni A, Bouamrani A, Ferrari M. Trends Pharmacol Sci. 2010;31:199.
Ehrlich PH. J Theor Biol. 1979;81:123.
Ehrlich PH, Matsueda GR, Haber E, Margolies MN. Biochemistry. 1979;18:4411.
Roux KH. Int Arch Allergy Immunol. 1999;120:85.
Janeway Jr CA. Cold Spring Harb Symp Quant Biol. 1989;54:Pt 1, 1.
Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. Nature. 1997;388:394.
Iwasaki A, Medzhitov R. Science. 2010;327:291.
Rader DJ, Daugherty A. Nature. 2008;451:904.
Hansson GK. N Engl J Med. 2005;352:1685.
Goldstein JL, Brown MS. Med Clin North Am. 1982;66:335.
Goldstein JL, Kottke BA, Brown MS. Prog Clin Biol Res. 1982;103(Pt B):161.
Schneider WJ, Beisiegel U, Goldstein JL, Brown MS. J Biol Chem. 1982;257:2664.
Tolleshaug H, Goldstein JL, Schneider WJ, Brown MS. Cell. 1982;30:715.
Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. JAMA. 2003;290:2292.
Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A. Arterioscler Thromb Vasc Biol. 2007;27:661.
Benn M, Stene MC, Nordestgaard BG, Jensen GB, Steffensen R, Tybjaerg-Hansen A. J Clin Endocrinol Metab. 2008;93:1038.
Duncan R. Nat Rev Drug Discov. 2003;2:347.
Watson DS, Endsley AN, Huang L. Vaccine. 2012;30:2256.
Naito M, Kudo I, Mukai-Sato Y, Tsushima S, Nomura H, Nojima S, Inoue K. Cancer Immunol Immunother. 1987;24:158.
Trivedi RA, Mallawarachi C, JM UK-I, Graves MJ, Horsley J, Goddard MJ, Brown A, Wang L, Kirkpatrick PJ, Brown J, Gillard JH. Arterioscler Thromb Vasc Biol. 2006;26:1601.
Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, Weissleder R. Circulation. 2006;114:1504.
Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, Kohler RH, Shi GP, Libby P, Weissleder R. Circulation. 2007;115:2292.
Hyafil F, Cornily JC, Feig JE, Gordon R, Vucic E, Amirbekian V, Fisher EA, Fuster V, Feldman LJ, Fayad ZA. Nat Med. 2007;13:636.
de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Arterioscler Thromb. 1991;11:298.
Hurt-Camejo E, Olsson U, Wiklund O, Bondjers G, Camejo G. Arterioscler Thromb Vasc Biol. 1997;17:1011.
Shinde Patil VR, Campbell CJ, Yun YH, Slack SM, Goetz DJ. Biophys J. 2001;80:1733.
Lamprecht A, Schafer U, Lehr CM. Pharm Res. 2001;18:788.
Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Biochem J. 2004;377:159.
Gratton SE, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM. Proc Natl Acad Sci U S A. 2008;105:11613.
Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Nat Biotechnol. 2007;25:1165.
Choi HS, Ipe BI, Misra P, Lee JH, Bawendi MG, Frangioni JV. Nano Lett. 2009;9:2354.
Kobayashi H, Kawamoto S, Jo SK, Bryant Jr HL, Brechbiel MW, Star RA. Bioconjug Chem. 2003;14:388.
Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. J Clin Invest. 1998;101:1084.
Gofman JW, Lindgren F. Science. 1950;111:166.
Gofman JW, Lindgren FT, Elliott H. J Biol Chem. 1949;179:973.
Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Nature. 2002;417:750.
Verma A, Stellacci F. Small. 2010;6:12.
Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S. Proc Natl Acad Sci U S A. 2007;104:2050.
Schellenberger EA, Bogdanov Jr A, Hogemann D, Tait J, Weissleder R, Josephson L. Mol Imaging. 2002;1:102.
Tassa C, Shaw SY, Weissleder R. Acc Chem Res. 2011;44:842.
Sosnovik DE, Schellenberger EA, Nahrendorf M, Novikov MS, Matsui T, Dai G, Reynolds F, Grazette L, Rosenzweig A, Weissleder R, Josephson L. Magn Reson Med. 2005;54:718.
Krieger M, Herz J. Annu Rev Biochem. 1994;63:601.
Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Nature. 1990;343:531.
Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Nature. 1990;343:570.
Thomas TP, Goonewardena SN, Majoros IJ, Kotlyar A, Cao Z, Leroueil PR, Baker Jr JR. Arthritis Rheum. 2011;63:2671.
Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker Jr JR. Cancer Res. 2005;65:5317.
Peer D, Park EJ, Morishita Y, Carman CV, Shimaoka M. Science. 2008;319:627.
Winter PM, Neubauer AM, Caruthers SD, Harris TD, Robertson JD, Williams TA, Schmieder AH, Hu G, Allen JS, Lacy EK, Zhang H, Wickline SA, Lanza GM. Arterioscler Thromb Vasc Biol. 2006;26:2103.
Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Proc Natl Acad Sci U S A. 2007;104:961.
Uziely B, Jeffers S, Isacson R, Kutsch K, Wei-Tsao D, Yehoshua Z, Libson E, Muggia FM, Gabizon A. J Clin Oncol. 1995;13:1777.
Lanza GM, Winter PM, Caruthers SD, Hughes MS, Cyrus T, Marsh JN, Neubauer AM, Partlow KC, Wickline SA. Nanomedicine (Lond). 2006;1:321.
Acknowledgments
I would like to thank the late Charles A. Janeway, Jr., Ruslan M. Medzhitov, Joe G.N. Garcia, and James R. Baker, Jr. whose work inspired what we have done and will do.
Disclosure
No conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goonewardena, S.N. Approaching the Asymptote: Obstacles and Opportunities for Nanomedicine in Cardiovascular Disease. Curr Atheroscler Rep 14, 247–253 (2012). https://doi.org/10.1007/s11883-012-0249-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11883-012-0249-9